Contineum Therapeutics, Inc.
CTNM
$14.19
-$1.11-7.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.80% | 29.16% | 28.39% | -14.73% | -19.74% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 344.94% | 366.01% | 208.42% | 104.55% | -18.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 37.18% | 31.66% | 29.81% | -14.04% | -19.74% |
|
|
|||||
| Total Current Assets | 37.18% | 31.66% | 29.81% | -14.04% | -19.74% |
| Net Property, Plant & Equipment | 26.61% | 31.78% | 31.18% | 536.71% | 468.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 95.70% | 7,700.00% | 8,433.33% | 8,766.67% | 6,100.00% |
| Total Assets | 36.90% | 31.82% | 29.97% | -11.66% | -17.38% |
|
|
|||||
| Total Accounts Payable | -74.76% | -58.98% | -43.90% | -43.74% | 172.62% |
| Total Accrued Expenses | -3.18% | -25.72% | -4.83% | 7.90% | 48.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 63.23% | 58.28% | 61.23% | 141.73% | 202.89% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -9.54% | -25.61% | -2.31% | 9.56% | 92.94% |
|
|
|||||
| Total Current Liabilities | -9.54% | -25.61% | -2.31% | 9.56% | 92.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.40% | 2.29% | 22.92% | -- | 3,691.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -6.88% | -16.21% | 5.90% | 78.73% | 198.49% |
|
|
|||||
| Common Stock & APIC | 39.46% | 39.04% | 38.91% | 9.58% | 3.38% |
| Retained Earnings | -38.52% | -43.81% | -51.09% | -57.75% | -61.43% |
| Treasury Stock & Other | -489.80% | -248.82% | 266.20% | -52.76% | 215.75% |
| Total Common Equity | 39.83% | 35.33% | 31.77% | -14.16% | -21.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 39.83% | 35.33% | 31.77% | -14.16% | -21.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 39.83% | 35.33% | 31.77% | -14.16% | -21.20% |
|
|
|||||